Sanofi Applies In Japan For First Global Approval Of Type 2 Diabetes Drug
This article was originally published in PharmAsia News
Executive Summary
Sanofi filed an application in Japan for the world's first approval of its Lyxumia (lixisenetide) for treating type 2 diabetes.